Fairfield, Bush & Co’s Qiagen QGEN Stock Holding History

Fairfield, Bush & Co’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-44	Closed	-$2.04K	–	389
2023 Q4	$2.04K	Buy	+44	New	+$1.87K	﹤0.01%	390
2023 Q3	–	Sell	-44	Closed	-$2.12K	–	405
2023 Q2	$2.12K	Buy	+44	New	+$2.12K	﹤0.01%	413
2022 Q3	–	Sell	-44	Closed	-$2K	–	374
2022 Q2	$2K	Buy	+44	New	+$2.15K	﹤0.01%	400

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Fairfield, Bush & Co's QGEN Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Qiagen (QGEN) in Q1 2024, closing a stake of 44 shares — an estimated $2.04K sold.

Fairfield, Bush & Co first reported a position in QGEN in Q2 2022 and held it in 3 quarters. The position peaked at $2.12K in Q2 2023. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

Fairfield, Bush & Co reported no remaining Qiagen position as of Q1 2024 after selling out during the quarter.
Fairfield, Bush & Co sold 44 Qiagen shares in Q1 2024, an estimated $2.04K.
Fairfield, Bush & Co first reported a position in Qiagen in Q2 2022 and held it in 3 quarters.
Fairfield, Bush & Co's Qiagen position peaked at $2.12K in Q2 2023.
282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.